The New York Genome Center and IBM using Watson supercomputer to advance genome sequencing, cancer treatment

Watson, the computer that became famous for winning Jeopardy!, is in the news again, in its new role as a medical diagnostic genius. The New York Genome Center (NYGC), along with IBM, is using a unique Watson prototype to help oncologists deliver better care to patients with glioblastoma, an aggressive form of brain tumor that kills 13,000 people in the US yearly.

Patients with a glioblastoma diagnosis and their doctors often find that their cancer responds to different forms of treatment, depending on what kind of specific genetic mutation has caused the tumor. In the current study, experts at the NYGC are evaluating Watson’s ability to detect these mutations and recommend the most effective form of treatment for patients. To do this, the computer must correlate gene sequencing data with the latest findings from medical journals, clinical data, and new studies that are being published daily, a task that would be extremely time-consuming for human researchers in cases where there is no time to lose.

Perhaps the most interesting thing about how Watson goes through the complex research process is its ability to continually “learn” by incorporating new patient cases and medical findings into its database. Watson’s ability to tailor treatment recommendations faster and more accurately will increase over time, which could prove to be lifesaving for a large number of cancer patients.

The NYGC’s glioblastoma study is just the first step in opening new possibilities and opportunities to use medical “big data” to deliver more personalized patient care. As genetic scientists, computer scientists, and physicians continue to refine Watson’s capabilities, this new technology could result in countless lives saved, as well as improved quality of life for patients undergoing treatment for cancer and other diseases.

Source: “IBM’s Watson Takes on Brain Cancer” IBM Research. http://www.research.ibm.com/articles/genomics.shtml

Resolution Research will attend the New York Times Health For Tomorrow Conference

Nina Nichols, CEO of Resolution Research, will be attending the New York Times Health For Tomorrow Conference to promote Resolution’s new research platform for medical professionals, The Medical Panel. NYT Health for Tomorrow is one of the most cutting-edge professional conferences in the health and medicine field, including innovators in using mobile technology and social media to promote health and wellness for consumers, as well as greater efficiency and effectiveness for doctors and other medical practitioners.

The conference brings together over 300 experts not just from clinical medicine, but also from the business world, academia, nonprofits, and government to discuss the challenges and opportunities that face medical practitioners in today’s rapidly changing landscape of technology, economics, and globalization. Topics addressed will include health care reform, the costs of medical care, the benefits and hazards of rapidly advancing new technology, and new demands on medical professionals.

This year’s forum is taking place at the University of California in San Francisco May 28-29, and features a wide variety of leaders, influencers and innovators in all fields of medicine. These include Dr. Toby Cosgrove, CEO of Cleveland Clinic (included on Modern Healthcare’s list of the 100 most powerful people in the medical field) and Janet Napolitano, President of the University of California and former US Secretary of Homeland Security, as well as Halle Tecco, CEO of Rock Health, a seed fund for digital health companies.

This conference will be a great opportunity for Resolution Research to network with top medical influencers and spread the word about our new Medical Panel site, set to go live shortly before the conference. We want medical professionals from all fields, including physicians, healthcare information experts, executives, administrators, and biotechnologists, to know that The Medical Panel will be their source to participate in paid research studies, collaborate with colleagues near and far, and access the most recent medical information and resources.

Source: New York Times Health For Tomorrow Conference: http://www.nythealthfortomorrow.com/